Presenter: Rob Phoenix, APRN, FNP-C, HIV-PCP
Online CME Credit
Fee: Free
Provides 1.00 hour of CE/CME credit (Presented on March 21, 2023, Reviewed July 1, 2024; Expires June 30, 2025)
Presenter: Rob Phoenix, APRN, FNP-C, HIV-PCP
Online CME Credit
Fee: Free
Provides 1.00 hour of CE/CME credit (Presented on March 21, 2023, Reviewed July 1, 2024; Expires June 30, 2025)
This virtual training is in collaboration with the Nevada Primary Care Association. This program will cover prescribing pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), performing an HIV risk assessment, and discussing HIV prevention with patients. This session will also include a skill-building portion for participants.
Following participation in this course, participants should be able to:
The Pacific AETC-NV offers engaging and interactive online learning opportunities to increase healthcare providers' knowledge and awareness of HIV and STI-related health topics. To view all session topics available, please click on Pacific AETC Nevada’s E-Learning page for more online and on-demand learning opportunities.
Rob Phoenix, APRN, FNP-C, HIV-PCP, Nurse Practitioner, Huntridge Family Clinic, Faculty, Pacific AETC-Nevada
The Pacific AETC is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award $3,887,700.00. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.
Please follow the link to register with the Pacific AETC Nevada’s E-Learning program. In order to continue funding and provide educational programming for health professionals around HIV/AIDS, we need all participants to register through PAETC-NV.
This webinar requires you to login into the University of Nevada, Reno School of Medicine, Office of Continuing Medical Education’s (UNR Med CME) website to complete your registration. If you do not have a UNR Med CME account, you will need to make one.
Once you have signed into the UNR Med CME websites, follow the instructions below to watch the webinar and collect your CME, CE, and pharmacy credit.
If you have any questions, please email us at paetcnv@med.unr.edu.
For questions concerning the online evaluation or your certificate, please contact our office at (775) 784-4791 or email us at cme@med.unr.edu.
The University of Nevada, Reno School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Nevada, Reno School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Nevada, Reno School of Medicine approves this program for 1.00 hour of nursing continuing education credit.
As an accredited provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME) the University of Nevada, Reno School of Medicine must ensure balance, independence, objectivity, and scientific rigor in all its educational activities. In order to assure that information is presented in a scientific and objective manner, The University of Nevada, Reno School of Medicine requires that anyone in a position to control or influence the content of an accredited activity disclose all financial relationships within the prior 24 months with any commercial or proprietary entity producing health care goods or services relevant to the content being planned or presented. All relevant financial relationships have been mitigated. Following are those disclosures.
The following presenter has disclosed the following relationship with a commercial interest.
Presenters
Rob Phoenix, APRN, FNP-C, HIV-PCP: Grant/Research Support: Gilead Sciences; Consultant: Gilead Sciences, Lupin Pharmaceutical, Janssen Pharmaceutical, ViiV medical; Speakers’ Bureau or Honoraria: Gilead Sciences, NAPO Pharmaceutical, ViiV Medical; Ownership Interest: Huntridge Family Clinic-100%
All other presenters, planners or anyone in a position to control the content of this continuing medical education activity have indicated that they do not have financial relationships with ineligible companies related to the content of this activity.
Ard, K. L. (2022, April 20). New PrEP Guidelines. Retrieved from National LGBTQI+ Health Center Education Center LearningResources: https://www.lgbtqiahealtheducation.org/courses/new-prep-guidelines/
Brawley, S. (2020, July 6–10). Impact of COVID-19 related shelter in place orders on PrEP access, usage and HIV risk factorsin the United States [conference presentation]. International AIDS Conference, Virtual,Virtual. https://natap.org/2020/IAC/IAC_35.htm
Curanovic, D., Camarillo, J., Petropoulos, C., & Walworth, C. (2021, July 18–21). Decline in HIV testing and changes inpositivity rates during the COVID 19 pandemic. 11th IAS Conference on HIV Science, Virtual. chrome-extension://oemmndcbldboiebfnladdacbdfmadadm/https://www.natap.org/
2021/IAS/IAS2021DeclineHIVestingfinal.pdf
Eshleman, S. (2023). The LEVI syndrome: Characteristics of early HIV infection with cabotegravire for PrEP. Conference onRetroviruses and Opportunistic Infections. Seattle.
Hennepin Healthcare. (2023). Doxycycline does not prevent STIs among cisgender women. Conference on Retroviruses andOpportunistic Infections. Seattle.
Karunakaran, D., Simpson, S. M., Su, J. T., Bryndza-Tfaily, E., Hope, T. J., Veazey, R., Dobek, G., Qiu, J., Watrous, D., Sung,S., Chacon, J. E., & Kiser, P. F. (2021). Design and testing of a cabotegravir implant for hiv prevention. Journal of ControlledRelease, 330, 658–668. Retrieved October 3, 2021, from https://doi.org/10.1016/j.jconrel.2020.12.024
National LGBT Health Education Center. (2022). HIV Prevention in Health Centers Train the Trainer. Retrieved from NationalGGBTQIA+ Heath Education resources.